Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

10-years Clinical Trial of Sealed of Margin Failures (Sealant)

27. Februar 2014 aktualisiert von: Gustavo Moncada, University of Chile

Longitudinal Results of a 10-years Clinical Trial of Sealed Margin Failures of Amalgam Restorations

  • Assess the effectiveness of sealing localized marginal defects of amalgam restorations that were initially scheduled for replacement of restorations.
  • The hypothesis was that sealed defective margins of the amalgam restorations shows similar performance than replacement amalgam restorations.

Studienübersicht

Detaillierte Beschreibung

Study Design

Were examined 157 patients with 586 amalgam restorations that were recruited at the Operative Dentistry Clinic, at the Dental School, University of Chile with the indication of amalgam replacements, of them, a cohort of thirty two patients (19 females and 13 males, mean age = 27 years old), with 73 Class I amalgam restorations, that presented one or more localized margin defects (Bravo or Charlie according to modified United State Public Health Service, USPHS criteria), were included in the study. The protocol was approved by the Institutional Research Ethics Committee of the Dental School at the University of Chile, Investigation Project, School of Dentistry (0205) and all patients signed the informed consent form and completed the registration form. Only Faculty members were accepted to provide the treatment.

Treatment Groups Criteria: 73 restorations with defective margins were evaluated in accordance with the modified USPHS criteria and assigned to either the sealant (n=26), repair (n=21) and control groups (n=26).

Restorations Assessment: The quality of the restorations were evaluated using the modified U.S. Public Health System/Ryge criteria. Two examiners assessed the restorations independently and by visual and tactile (mouth mirror number 5) examination using an explorer (N° 23) and indirectly by radiographic, examination, for interproximal observation (Bite Wing). All the restorations were examined at baseline and each year during four and ten years after treatment. The restorations assessment was carried out by five parameters: marginal adaptation (MA), roughness (R), secondary caries (SC), marginal stain (MS) and teeth sensitivity (TS). If any difference was recorded between the 2 independent examiners, and they did not reach an agreement, a third clinician was called to assist with the process decision. If the three clinicians they did not reach an agreement, the lower score was recorded. All three clinicians participated in calibration exercises at the beginning and before the last examination took place and the inter-examiner reliability results were Kappa=0.74 at the baseline and Kappa=0.87 at the ten year.

A change from Bravo to Alpha was considered an improvement and a change from Alpha to Bravo was considered downgrade.

Caries risk assessment: A graphical computed program (CARIOGRAM) was used for individual´s patients caries risk assessed, the program weighted the interaction between the following 10 caries related factors: Caries experience, related general disease, diet contents, diet frequency, plaque amount by Silness Löe Index, semi quantitative detection of mutans streptococci and lactobacilli in saliva by Caries Risk Test (CRT), fluoride program, amount of saliva stimulated secretion by CRT Buffer (Vivadent), saliva buffer capacity and clinical judgment. Patients were classifying in high, intermediate and low caries risk. Additionally the results also indicate where targeted actions to improve the situation will have the best effect.

Patients were recalled ten years after the treatment, for clinical assessment by the same examiners, applying the same criteria used at baseline. Failed restorations were removed from the study and treated according to the diagnosed needs.

Statistical analysis The ordinal dependent variable was changed in level of the modified USPHS criteria from the baseline value. The assigned score of each restoration reflected the worst result for any of the parameters. The results of each group in terms of degradation or upgrade were analyzed by Friedman range non-parametric test to compare the pre and postoperative conditions. Additionally, the performance of all groups was contrasted using the Mann Whitney test to determine the differences between the upgrade and downgrade of the restoration´s quality. The statistical significance was set at 95%, α=0.05 and β=0.80 for statistical analysis.

Studientyp

Beobachtungs

Einschreibung (Tatsächlich)

32

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienorte

    • Region Metropolitana
      • Santiago, Region Metropolitana, Chile
        • University of Chile

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

18 Jahre bis 80 Jahre (Erwachsene, Älterer Erwachsener)

Akzeptiert gesunde Freiwillige

Ja

Studienberechtigte Geschlechter

Alle

Probenahmeverfahren

Wahrscheinlichkeitsstichprobe

Studienpopulation

Patients of the Operative Dentistry Clinics, School of Dentistry, University of Chile

Beschreibung

Inclusion criteria:

  • Patients with amalgam restorations with marginal deficiencies that were judged to be suitable for sealing.
  • Older than 18 years of age ¨
  • More than 20 teeth in their mouth
  • The restorations had to be in functional occlusion with an opposing natural tooth
  • With at least one proximal contact area with and adjacent tooth
  • Area out of the restoration´s failures in good condition
  • Patients who agree and sign the informed consent for participating in the study.

Exclusion Criteria:

  • Patients with contraindications for regular dental treatment based on their medical history
  • Special aesthetic requirements that could not be solved by this alternative treatment
  • Xerostomia or who were taking medication that significantly decreased salivary flow
  • High caries risk
  • Psychiatric or physical diseases, that interfered with teeth hygiene.

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

Kohorten und Interventionen

Gruppe / Kohorte
Intervention / Behandlung
Defective amalgam restorations

Treatment Groups:

A. Sealing of amalgam margin defects: Defective areas were acid etched with 35% phosphoric acid for 15 seconds. A resin-based sealant (Sealant, 3MESPE)was applied over the defective area. The sealant was polymerized with a photo curing unit (Curing-Light 2500, 3MESPE) for 40 seconds. Rubber dam isolation was used for this procedure. All treatments were applied by the same clinician.

B. Replacement Group: The clinician totally removed and replaces the defective restoration with a new amalgam (Tytin, Kerr, Orange, USA). Rubber dam isolation was used for this procedure. All treatments were applied by the same clinician.

C. Control Group: The defective restorations did not receive any treatment.

Comparison between sealing of amalgam margins defects, replacement and non treated groups.

A.Sealing of amalgam margin defects: were acid etched with 35% phosphoric acid for 15 seconds. A resin-based sealant (Clinpro Sealant, 3MESPE) was applied over the defective area. The sealant was polymerized with a photocuring unit (Curing Light 2500, 3M ESPE) for 40 seconds. Rubber dam isolation was used for this procedure. All treatments were applied by the same clinician.

B.Replacement Group: The clinician totally removed and replaces the defective restoration with a new amalgam (Tytin, Kerr Corporation, Orange, CA, USA). Rubber dam isolation was used for this procedure. All treatments were applied by the same clinician.

C.Control Group: The defective restorations did not receive any treatment.

Andere Namen:
  • Use of Selant to seal amalgam margins defects

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Changes of Amalgam restorations quality according to United Stated Public Health Service (USPHS)
Zeitfenster: Baseline and 10 after treatment
Restorations Assessment: The quality of the restorations were evaluated using the modified U.S. Public Health System criteria. Two examiners assessed the restorations independently and by visual and tactile examination. All the restorations were examined at baseline and ten years after treatment. The restorations assessment was carried out by five parameters: marginal adaptation, roughness, secondary caries, marginal stain and teeth sensitivity. All three clinicians participated in calibration exercises at the beginning and before the last examination took place and the inter-examiner reliability results were Kappa=0.74 at the baseline and Kappa=0.87 at the ten year.
Baseline and 10 after treatment

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Ermittler

  • Hauptermittler: Gustavo Moncada, DDS, University of Chile

Publikationen und hilfreiche Links

Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.

Allgemeine Veröffentlichungen

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn

1. August 2003

Primärer Abschluss (Tatsächlich)

1. Februar 2014

Studienabschluss (Tatsächlich)

1. Februar 2014

Studienanmeldedaten

Zuerst eingereicht

21. Februar 2014

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

27. Februar 2014

Zuerst gepostet (Schätzen)

3. März 2014

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Schätzen)

3. März 2014

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

27. Februar 2014

Zuletzt verifiziert

1. Februar 2014

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Andere Studien-ID-Nummern

  • PRI-ODO-0207

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Abonnieren